Can-Fite BioPharma Ltd. (CANF) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 | Q3'20 |
|---|
| Total Current Assets | 7.62M | 7.62M | 8.98M | 8.98M | 5.83M | 5.83M | 9.91M | 9.06M | 10.91M | 13.38M | 9.16M | 12.56M | 14.59M | 17.67M | 20.07M | 14.47M | 9.55M | 12.63M | 9.4M | 13.24M |
| Cash & Short-Term Investments | 6.46M | 6.46M | 7.89M | 7.89M | 4.73M | 4.73M | 8.92M | 7.94M | 9.62M | 12.42M | 7.99M | 10.81M | 12.77M | 16.7M | 19.14M | 13.66M | 7.81M | 11.61M | 8.34M | 10.28M |
| Cash Only | 6.45M | 6.45M | 4.83M | 4.83M | 4.72M | 4.72M | 4.28M | 3.38M | 3.46M | 1.26M | 2.98M | 3.73M | 1.71M | 5.5M | 4.39M | 5.81M | 1.02M | 2.74M | 8.27M | 10.22M |
| Short-Term Investments | 2K | 2K | 3.06M | 3.06M | 9K | 9K | 4.64M | 4.56M | 6.16M | 11.15M | 5.01M | 7.09M | 11.05M | 11.2M | 14.75M | 7.86M | 6.78M | 8.87M | 75K | 57K |
| Accounts Receivable | 0 | 0 | 77K | 0 | 0 | 0 | 78K | 0 | 0 | 0 | 47K | 0 | 0 | 0 | 48K | 811K | 1.75M | 1.02M | 18K | 2.96M |
| Days Sales Outstanding | - | - | 157.01 | - | - | - | 183.68 | - | - | - | 87.08 | - | - | - | 85.88 | 1.18K | 2.55K | 2.51K | 43.8 | 5.12K |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -811K | -1.75M | -1.02M | 0 | -2.96M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 1.02M | 77K | 0 | 0 | 0 | 1.12M | 1.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 96K | 96K | 138K | 138K | 94K | 94K | 81K | 105K | 123K | 110K | 126K | 141K | 157K | 174K | 185K | 165K | 127K | 117K | 123K | 86K |
| Property, Plant & Equipment | 96K | 96K | 138K | 138K | 94K | 94K | 81K | 105K | 123K | 110K | 126K | 141K | 157K | 174K | 185K | 165K | 127K | 117K | 123K | 86K |
| Fixed Asset Turnover | 1.05x | 1.05x | 1.30x | 1.30x | 1.68x | 1.68x | 1.91x | 1.87x | 1.59x | 1.78x | 1.56x | 1.45x | 1.30x | 1.18x | 1.10x | 1.52x | 1.97x | 1.26x | 1.22x | 2.45x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -105K | -123K | -110K | -126K | -141K | -157K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 7.72M | 7.72M | 9.12M | 9.12M | 5.92M | 5.92M | 9.99M | 9.17M | 11.03M | 13.49M | 9.28M | 12.71M | 14.75M | 17.85M | 20.25M | 14.64M | 9.68M | 12.74M | 9.52M | 13.33M |
| Asset Turnover | 0.01x | 0.01x | 0.02x | 0.02x | 0.03x | 0.03x | 0.02x | 0.02x | 0.02x | 0.01x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.02x | 0.03x | 0.01x | 0.02x | 0.02x |
| Asset Growth % | 30.36% | 30.36% | -8.7% | -0.53% | -46.32% | -56.1% | 7.61% | -27.84% | -25.19% | -24.42% | -54.16% | -13.2% | 52.33% | 40.06% | 112.67% | 9.85% | -24.38% | 29.39% | 16.49% | 13.4% |
| Total Current Liabilities | 2.12M | 2.12M | 2.05M | 2.05M | 1.99M | 1.99M | 2.02M | 2.21M | 2.23M | 2.89M | 2.5M | 2.8M | 2.15M | 2.9M | 2.73M | 2.15M | 2.36M | 2.06M | 1.27M | 1.82M |
| Accounts Payable | 1.15M | 1.15M | 618K | 618K | 885K | 885K | 427K | 647K | 810K | 963K | 896K | 1.47M | 824K | 1.12M | 954K | 806K | 1M | 290K | 561K | 784K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 53K | 0 | 0 | 0 | 27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 405K | 0 | 405K | 0 | 636K | 0 | 622K | 783K | 783K | 783K | 783K | 818K | 818K | 818K | 818K | 1M | 1M | 1M | 334K | 603K |
| Other Current Liabilities | 0 | 405K | 622K | 405K | 0 | 636K | 667K | 0 | 0 | 0 | 492K | 0 | 0 | 0 | 603K | 0 | 0 | 0 | 96K | 0 |
| Current Ratio | 3.60x | 3.60x | 4.38x | 4.38x | 2.93x | 2.93x | 4.90x | 4.10x | 4.89x | 4.63x | 3.66x | 4.49x | 6.78x | 6.09x | 7.35x | 6.72x | 4.05x | 6.13x | 7.41x | 7.28x |
| Quick Ratio | 3.60x | 3.60x | 4.38x | 4.38x | 2.93x | 2.93x | 4.90x | 4.10x | 4.89x | 4.63x | 3.66x | 4.49x | 6.78x | 6.09x | 7.35x | 7.10x | 4.79x | 6.63x | 7.41x | 8.91x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.42M | 1.42M | 1.63M | 1.63M | 1.46M | 1.46M | 1.73M | 1.72M | 1.93M | 2.1M | 2.31M | 2.48M | 2.7M | 2.92M | 3.14M | 3.15M | 3.37M | 3.6M | 2.18M | 1.97M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 33K | 33K | 51K | 51K | 21K | 21K | 13K | 17K | 22K | 6K | 14K | 26K | 40K | 54K | 71K | 62K | 25K | 14K | 24K | 15K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.71M | -1.9M | -2.1M | -2.29M | -2.46M | -2.66M | -2.87M | -3.07M | -3.09M | -3.34M | -3.59M | -2.16M | -1.95M |
| Other Non-Current Liabilities | 0 | 1.38M | 0 | 1.58M | 0 | 1.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.54M | 3.54M | 3.68M | 3.68M | 3.44M | 3.44M | 3.75M | 3.93M | 4.16M | 5M | 4.81M | 5.28M | 4.85M | 5.82M | 5.87M | 5.3M | 5.72M | 5.66M | 3.45M | 3.79M |
| Total Debt | 90K | 90K | 104K | 104K | 57K | 57K | 40K | 51K | 66K | 48K | 62K | 74K | 87K | 109K | 124K | 102K | 68K | 55K | 67K | 49K |
| Net Debt | -6.36M | -6.36M | -4.72M | -4.72M | -4.66M | -4.66M | -4.24M | -3.33M | -3.39M | -1.22M | -2.92M | -3.65M | -1.63M | -5.39M | -4.27M | -5.7M | -957K | -2.69M | -8.2M | -10.17M |
| Debt / Equity | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | -131.00x | -621.67x | - | - | -192.69x | - | -17.11x | -37.03x | -12.79x | - | -36.43x | - | -25.56x | -25.82x |
| Total Equity | 4.18M | 4.18M | 5.44M | 5.44M | 2.48M | 2.48M | 6.24M | 5.24M | 6.87M | 8.49M | 4.47M | 7.43M | 9.89M | 12.02M | 14.38M | 9.33M | 3.96M | 7.08M | 6.07M | 9.54M |
| Equity Growth % | 68.78% | 68.78% | -12.93% | 3.84% | -63.94% | -70.81% | 39.6% | -29.52% | -30.51% | -29.37% | -68.91% | -20.42% | 150.11% | 69.88% | 136.78% | -2.17% | -56.8% | 39.63% | 592.59% | 35.22% |
| Book Value per Share | 0.37 | 0.37 | 0.64 | 0.64 | 0.41 | 0.41 | 1.26 | 1.28 | 1.68 | 2.16 | 1.64 | 2.73 | 3.64 | 4.42 | 6.49 | 5.11 | 2.30 | 4.39 | 3.93 | 6.22 |
| Total Shareholders' Equity | 4.18M | 4.18M | 5.44M | 5.44M | 2.48M | 2.48M | 6.24M | 5.24M | 6.87M | 8.49M | 4.47M | 7.43M | 9.89M | 12.02M | 14.38M | 9.33M | 3.96M | 7.08M | 6.07M | 9.54M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60.65M | 60.65M | 60.65M | 60.65M | 43.72M | 37.01M | 37.01M | 33.04M | 32.94M |
| Retained Earnings | -171.24M | -171.24M | -166.36M | -166.36M | -162.44M | -162.44M | -158.48M | -156.83M | -155.07M | -153.4M | -150.85M | -147.83M | -145.3M | -143.11M | -140.67M | -133.97M | -130.57M | -127.35M | -125.47M | -121.84M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |